MIRA INFORM
REPORT
|
Report Date : |
19.01.2011 |
IDENTIFICATION DETAILS
|
Name : |
SANOFI AVENTIS |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2009 |
|
|
|
|
Year of Establishment : |
1961 |
|
|
|
|
Com. Reg. No.: |
106526, |
|
|
|
|
Legal Form : |
Egyptian Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacturers, packagers and distributors of
pharmaceutical products |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 2,500,000 |
|
Status : |
Good |
|
Payment
Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2010
|
Country Name |
Previous Rating (01.04.2010) |
Current Rating (30.06.2010) |
|
|
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SUMMARY
Company Name :
SANOFI AVENTIS
Country of Origin :
Legal Form : Egyptian Joint Stock Company
Registration Date : 1961
Commercial Registration Number :
106526,
Industrial Registration Number : 150
Chamber Licence Number : 0031
Issued Capital : £E 140,000,000
Paid up Capital : £E 140,000,000
Total Workforce : 900
Activities : Manufacturers, packagers and distributors of pharmaceutical products.
Financial Condition : Good
Payments : Nothing detrimental uncovered
Operating Trend : Steady
Recommended Credit Limit : US$ 2,500,000
COMPANY NAME
SANOFI AVENTIS
company ADDRESS
Registered & Physical Address
Street :
Area : Amireya, El
Zeitoun, Hadayek El Qobba
PO Box : 1486
Town :
Country :
Telephone : (20-2) 22845850 / 22845849 / 22845840
/ 22645850 / 22860010
Facsimile : (20-2) 22824855 / 22829027 /
22820906 / 22838488 / 22835278
Premises
Subject operates
from a large suite of offices and a factory that are rented and located in the
Central Business Area of Cairo.
Branch Office (s)
Location Description
·
Loran
Ramleh
KEY PRINCIPALS
Name Position
·
Dr
Ossama Mohamed El Saady Chairman
·
Marc Antoine Lucchini Managing
Director
·
Arnoud Dufoosez Director
·
Ihab El Shafie Director
·
Amgad Abd El Aal Finance
Manager
·
Dr Alaa El Sanan Advertising
Manager
·
Dr Amina El Karmany Administration
Manager
LEGAL FORM & OWNERS
Date of Establishment : 1961
Legal Form :
Egyptian Joint Stock
Company
Commercial Reg. No. : 106526,
Industrial Reg. No. : 150
Chamber Lic. No. : 0031
Issued Capital : £E 140,000,000
Paid up Capital : £E 140,000,000
Name of Shareholder
(s)
Percentage
·
Secipe 99%
·
Local
businessmen and private investors 1%
OPERATIONS
Activities : Engaged in the manufacture, packaging and
distribution of pharmaceutical products.
Import Countries :
International
Suppliers:
·
Sanofi
Aventis
Export
Countries:
Operating Trend: Steady
Subject has a
workforce of approximately 900 employees.
FINANCIAL DATA
Financial
highlights provided by local sources are given below:
Currency: Egyptian
Pounds (£E)
Year
Ending 31/12/08: Year
Ending 31/12/09:
Total Sales £E 653,820,479 £E 672,849,559
Local sources
consider subject’s financial condition to be Good.
The above financial
figures are based on estimations by our local sources.
BANKERS
·
Citibank
PO Box: 188
Tel: (20-2) 33551877 / 33551874
Fax:
(20-2) 33558056
PAYMENT HISTORY
No complaints
regarding subject’s payments have been reported.
GENERAL COMMENTS
Local sources report
that payment obligations are met in a generally timely manner and the operating
history is clear. As such the company is deemed a fair trade risk and the above
credit figure is considered to be within subject’s financial means.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.53 |
|
|
1 |
Rs.72.56 |
|
Euro |
1 |
Rs.60.62 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.